Immune thrombocytopenia

Haematopoiesis

Biology

Thrombopoietin

Stem cell

Eltrombopag

Romiplostim

Immunology

Genetics

Immune system

Internal medicine

Medicine

Gastroenterology

Thrombopoietin receptor

Rituximab

Antibody

Platelet

New England Journal of Medicine

Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.

Immune Thrombocytopenia